FloTrac®-guided haemodynamic resuscitation for profound cefuroxime-induced anaphylactic shock after induction of anaesthesia for cervical spine surgery: a case report

In the operating room, the body is often kept in a state of suspended animation, where the natural rhythms of breathing and heart function are managed by machines and medications. When a patient undergoes surgery, the medical team relies on a steady stream of data to ensure the body is receiving enough blood and oxygen. Usually, this involves watching the pressure in the arteries, a number that tells doctors how hard the heart is working to push blood through the vessels. However, there is a specific type of medical emergency where this pressure reading can be dangerously misleading. This happens when the immune system launches a sudden, massive attack against a substance it mistakenly believes is a threat, such as a medication. This reaction causes the tiny blood vessels throughout the body to widen uncontrollably and become leaky. Fluid that should stay inside the veins escapes into the surrounding tissues, and the blood vessels lose their ability to squeeze blood forward. In this state, the heart may be pumping vigorously, but the blood has nowhere to go, and the pressure drops to near zero. Understanding how to measure the actual flow of blood, rather than just the pressure, is critical for saving a life in these moments.

A recent case report from Malaysia details a terrifying instance of this exact scenario and describes how a specialized monitoring tool helped a team of doctors navigate the crisis. The patient was a forty-four-year-old woman scheduled for a routine surgery on her neck to relieve pain and numbness in her arm. She had a history of high blood pressure but was otherwise healthy and had no known allergies. The surgery began smoothly. The medical team administered standard medications to put her to sleep and relax her muscles, followed by an antibiotic called cefuroxime to prevent infection. Minutes after the antibiotic was given, the situation turned critical. The woman's airways suddenly tightened, making it impossible for the ventilator to push air into her lungs. Her skin flushed red, and her blood pressure, which had been stable, plummeted to a level so low that the machine could not even register a reading. The heart was racing, but the pulse was barely felt. The team immediately stopped the surgery and began administering emergency drugs to reverse the reaction, including epinephrine and fluids, but her condition remained unstable.

The medical team recognized that this was not a typical reaction to anesthesia but a severe allergic shock, known as anaphylaxis. The challenge was that the standard way of monitoring blood pressure was no longer telling the whole story. The pressure was low because the blood vessels were too wide and leaky, not necessarily because the heart had stopped pumping. To fix this, the doctors needed to know exactly how much fluid the patient had lost and how her heart was responding to the treatment. They turned to a sophisticated monitoring system called FloTrac, which analyzes the shape of the heartbeat wave in the arteries to calculate the actual volume of blood moving through the body with every beat. This system provided a live, second-by-second view of the patient's circulation that a standard blood pressure cuff could never offer.

The data from the monitor revealed the true extent of the damage. It showed that the patient had lost a massive amount of fluid from her blood vessels into her tissues, a condition known as capillary leak. The monitor indicated that her blood volume was critically low, a state that explained why her blood pressure was unmeasurable. Guided by these real-time numbers, the doctors began a precise and aggressive strategy to refill her blood vessels. They administered large amounts of fluid, watching the monitor to see if the blood flow improved. The system told them exactly when they had given enough fluid and when they needed to give more. At the same time, the monitor tracked the resistance in her blood vessels, allowing the doctors to carefully adjust the strength of the drugs keeping her blood pressure up. They could see instantly if a drug was working or if it was causing the vessels to squeeze too hard, which would strain the heart.

Over the next few days, this targeted approach allowed the patient to recover. The monitor showed that as the fluid levels were restored, the leak in her blood vessels began to close, and her blood flow stabilized. The doctors were able to slowly reduce the powerful drugs she needed to stay alive. By the third day, her blood chemistry had returned to normal, her heart was beating steadily without assistance, and she was breathing on her own. She was eventually taken off the breathing machine and transferred out of intensive care. Once she had recovered, the medical team performed detailed allergy tests to find the exact cause of the reaction. The tests confirmed that the antibiotic cefuroxime was the sole trigger. The results also showed that she was not allergic to the other drugs used during the surgery, such as the anesthesia or the muscle relaxants. This distinction was vital, as it meant she could safely undergo future surgeries without avoiding all medications, provided she avoided that specific antibiotic and similar ones.

This case highlights a crucial lesson in modern medicine: in a crisis where the body's circulation collapses, knowing the pressure is not enough. The FloTrac system provided a window into the actual mechanics of the blood flow, allowing the medical team to treat the root cause of the shock rather than just the symptoms. By using these advanced tools to guide their decisions, the doctors were able to navigate a life-threatening emergency with precision, restoring the patient's circulation and saving her life. The report serves as a powerful example of how real-time data can transform a chaotic medical emergency into a manageable situation, ensuring that treatment is tailored exactly to what the patient's body needs at that moment.